阿里健康(00241.HK)預計中期由盈轉虧不超3.2億元
格隆匯10月25日丨阿里健康(00241.HK)公吿,公司預期於截至2021年9月30日止六個月將錄得虧損淨額不多於人民幣3.2億元,而2020年同期利潤淨額則為約人民幣2.79億元。集團於2021財年首六個月錄得虧損淨額主要是由於以下各項的綜合影響:(i)集團增加資源配置以投入一系列創新業務如醫鹿APP、健康險等;(ii)集團在藥品倉儲物流等藥品供應鏈能力以及醫藥自營業務精細化運營、用户複診開方體驗、處方藥物合規安全等方面的技術研發持續投入;(iii)集團在天貓醫藥平台和阿里健康大藥房品牌心智建設加大投入;(iv)集團因提升線上B2C藥品銷售市佔率、加速處方藥業務佈局並增加相應市場投放帶來的自營業務利潤率降低;部分抵減於(v)投資的公允價值變動產生的未變現收益增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.